Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanam Shahid

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cancer Drug Resistance (Alhambra, Calif.)|September 6, 2021
Epstein-Barr virus-associated post-transplant lymphoproliferative disorders: beyond chemotherapy treatmentSanam Shahid, Susan E Prockop
Blood Advances|January 17, 2025
Predicting CAR T-cell toxicity: insurance for CAR crashesSanam Shahid, Kevin J Curran
Pediatric Hematology and Oncology|July 18, 2019
Iatrogenic immunodeficiency-associated lymphoproliferative disorder in a child with B-cell acute lymphoblastic leukemiaSanam Shahid, Christopher Rossi, Pranav Vyas, et al.
Pediatric Blood & Cancer|July 31, 2021
Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN-amplified neuroblastomaSanam Shahid, Brian H Kushner, Shakeel Modak, et al.
Pediatric Blood & Cancer|October 30, 2023
A quality improvement initiative standardizing premedication for blood product transfusionsSanam Shahid, Jaclyn Rosenzweig, Alexandre Troullioud Lucas, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Engineered NKG2C <sup>+</sup> NK-like T cells exhibit superior antitumor efficacy while mitigating cytokine release syndromeKyle B Lupo, M Kazim Panjwani, Sanam Shahid, et al.
Blood Advances|June 16, 2023
Immune profiling after allogeneic hematopoietic cell transplantation in pediatric acute myeloid leukemiaSanam Shahid, Nicholas Ceglia, Jean-Benoît Le Luduec, et al.
Transplantation and Cellular Therapy|December 1, 2021
Impact of Bridging Chemotherapy on Clinical Outcomes of CD19-Specific CAR T Cell Therapy in Children/Young Adults with Relapsed/Refractory B Cell Acute Lymphoblastic LeukemiaSanam Shahid, Kavitha Ramaswamy, Jessica Flynn, et al.
Cancer Discovery|August 11, 2025
Systematic evaluation of GAPs and GEFs identifies a targetable dependency for hematopoietic malignanciesPu Zhang, Zhendong Cao, Xiangyu Pan, et al.
Journal for Immunotherapy of Cancer|May 21, 2024
Developing a membrane-proximal CD33-targeting CAR T cellRuby Freeman, Sanam Shahid, Abdul G Khan, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cancer Drug Resistance (Alhambra, Calif.)|September 6, 2021
Epstein-Barr virus-associated post-transplant lymphoproliferative disorders: beyond chemotherapy treatmentSanam Shahid, Susan E Prockop
Blood Advances|January 17, 2025
Predicting CAR T-cell toxicity: insurance for CAR crashesSanam Shahid, Kevin J Curran
Pediatric Hematology and Oncology|July 18, 2019
Iatrogenic immunodeficiency-associated lymphoproliferative disorder in a child with B-cell acute lymphoblastic leukemiaSanam Shahid, Christopher Rossi, Pranav Vyas, et al.
Pediatric Blood & Cancer|July 31, 2021
Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN-amplified neuroblastomaSanam Shahid, Brian H Kushner, Shakeel Modak, et al.
Pediatric Blood & Cancer|October 30, 2023
A quality improvement initiative standardizing premedication for blood product transfusionsSanam Shahid, Jaclyn Rosenzweig, Alexandre Troullioud Lucas, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Engineered NKG2C <sup>+</sup> NK-like T cells exhibit superior antitumor efficacy while mitigating cytokine release syndromeKyle B Lupo, M Kazim Panjwani, Sanam Shahid, et al.
Blood Advances|June 16, 2023
Immune profiling after allogeneic hematopoietic cell transplantation in pediatric acute myeloid leukemiaSanam Shahid, Nicholas Ceglia, Jean-Benoît Le Luduec, et al.
Transplantation and Cellular Therapy|December 1, 2021
Impact of Bridging Chemotherapy on Clinical Outcomes of CD19-Specific CAR T Cell Therapy in Children/Young Adults with Relapsed/Refractory B Cell Acute Lymphoblastic LeukemiaSanam Shahid, Kavitha Ramaswamy, Jessica Flynn, et al.
Cancer Discovery|August 11, 2025
Systematic evaluation of GAPs and GEFs identifies a targetable dependency for hematopoietic malignanciesPu Zhang, Zhendong Cao, Xiangyu Pan, et al.
Journal for Immunotherapy of Cancer|May 21, 2024
Developing a membrane-proximal CD33-targeting CAR T cellRuby Freeman, Sanam Shahid, Abdul G Khan, et al.
Pageof 2